top of page
Blog
Jul 21 min read
THE EUROPEAN SOCIETY OF MEDICINE
Amyotrophic Lateral Sclerosis is a spectrum of diseases that needs a broad treatment approach Siobhan P Ellison DVM PhD1
35 views0 comments
May 222 min read
Clinical Trial FC-US-001
June 21, 2024 The last subjects for the clinical trial using FC-12738, affectionally called TVALA, had their final follow up visit on ...
49 views
May 222 min read
Richard H Helms 1949-2024
In hindsight, Richard Helms remembered he had a non-painful limp in 2018. After multiple consults he was introduced to ALS, that was in...
233 views
Mar 51 min read
TVALA Drug Trial
We are happy to announce the first patients are being screened for entry into the clinical trial for our drug TVALA! This Phase 1 study...
35 views0 comments
Dec 19, 20232 min read
MOLECULAR MECHANISMS OF REDOX REGULATION IN INFLAMMATION
We are hopeful that TVALA will reduce p53 expression in people with ALS. There are two recent publications that give us hope. The first...
24 views
Dec 1, 20231 min read
TVALA Fortune Journal
Pharmacological Characterization of FC-12738: A Novel Retro-Inverso Pentapeptide for Treating Neuroinflammation
36 views0 comments
Aug 10, 20231 min read
NDR starts clinical trial with TVALA
Neurodegenerative disease research is pleased to announce the progress of developing TVALA for the treatment of neuroinflammation in ALS....
35 views
Jan 24, 20231 min read
NDR publishes novel study
The preprint manuscript Assessment of levamisole HCl and thymosin α1 in two mouse models of amyotrophic lateral sclerosis by David R...
42 views
Dec 8, 20221 min read
Congratulations to Dr. Susanne Petri and her team!
NDR would like to congratulate Dr. Susanne Petri and her research team on their recent paper Altered Immunomodulatory Responses in the...
29 views
Nov 9, 20221 min read
NDR awards Dr. Chandler Walker $1.1 Million for ALS Research
Dr. Chandler Walker, associate professor in the Department of Biomedical Sciences and Comprehensive Care at Indiana University School of ...
49 views
Sep 29, 20221 min read
Ghada Maged receives NDR student award
NDR is pleased to announce research support for Ghada Maged for an ALS biomarkers project. Ms. Maged is currently completing an M. Sc....
26 views
Sep 16, 20221 min read
A Personal Message from Dr. Siddique
In this final installment, Dr. Siddique delivers a personal message.
17 views
Sep 12, 20221 min read
Second Video Installment
In this second installment, Dr. Siddique discusses the future of ALS research and its implications for researchers and patients. We hope...
13 views
Sep 7, 20221 min read
New Video Series
We're pleased to announce that Northwestern University-Feinberg School of Medicine has produced a three-part video series on ALS,...
21 views
Aug 31, 20221 min read
NDR's TVALA® Trademarked
The lead molecule under development by NDR for treating neuroinflammation is the retro-inverso thymopentin, TVALA®. The application for...
113 views
May 9, 20221 min read
Sayuri Miyamoto to present a poster at the Paris Redox 2022 World Conference
NDR is pleased to congratulate Dr. Sayuri Miyamoto and her co-workers Adriano Chaves-Filho, Rosangela Santos, Rodrigo Lima, Larissa...
18 views
Mar 8, 20221 min read
Dr. Susanne Petri Joins NDR Scientific Group
NDR Inc is pleased to announce that Dr. Susanne Petri has joined our scientific group. Dr. Petri is an Associate Professor in the...
24 views
Jan 14, 20221 min read
NDR awards $1.54 M drug development contract to WuXi App Tec
New drug development
38 views
bottom of page